|
Volumn 334, Issue 6055, 2011, Pages 462-463
|
Getting the farm out of pharma for heparin production
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHONDROITIN SULFATE;
FONDAPARINUX;
HEPARAN SULFATE;
HEPARIN;
RECOMBINANT ENZYME;
ANTICOAGULANT AGENT;
LOW MOLECULAR WEIGHT HEPARIN;
ANIMAL PRODUCT;
BLOOD;
COAGULATION;
DISEASE TREATMENT;
DRUG;
ENZYME ACTIVITY;
INDUSTRIAL PRODUCTION;
POLLUTANT SOURCE;
POLLUTION CONTROL;
POLYSACCHARIDE;
QUALITY CONTROL;
ALLERGIC REACTION;
ANTICOAGULATION;
DRUG FATALITY;
FARM ANIMAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE INDUSTRY;
HUMAN;
HYPERSENSITIVITY REACTION;
INDUSTRIAL PRODUCTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
REVIEW;
SWINE;
SYNTHESIS;
UNITED STATES;
ANIMAL;
NOTE;
ANIMALIA;
ANIMALS;
ANTICOAGULANTS;
HEPARIN, LOW-MOLECULAR-WEIGHT;
|
EID: 80055090610
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1211605 Document Type: Review |
Times cited : (21)
|
References (17)
|